ConductScience.org, home

Paper5111740

Clinical trials with adriamycin.

Middleman E and 2 others. Cancer, 1971. Cited by 265 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Clinical trials with adriamycin. Papers, record 5111740. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/5111740

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Clinical trials with adriamycin.
PubMed
Journal
Cancer
PubMed
Year
1971
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
265
iCite
Relative citation ratio, by iCite
7.12
iCite
Revised in PubMed
2019-06-20
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Middleman EE
2Luce JJ
3Frei E 3rdE

Source PubMed

Topics21

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibiotics, AntineoplasticMajor topic
Adenocarcinoma
Adolescent
Adult
Aged
Breast Neoplasms
Carcinoma, Squamous Cell
Carcinoma, Transitional Cell
Female
Gastrointestinal Neoplasms
Humans
Kidney Neoplasms
Leukemia
Liposarcoma
Male
Melanoma
Middle Aged
Sarcoma
Skin Neoplasms
Testicular Neoplasms
Thyroid Neoplasms

Source PubMed

Cited by45

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 265 citations.

PMIDTitleJournalYearIn PapersSource
41,924,873Safety and Treatment Efficacy of Systemic, Locoregional, and Nanoparticle Encapsulated Anthracycline Chemotherapy: Insights Into Cardiotoxicity.Arterioscler Thromb Vasc Biol2026https://conductscience.org/library/papers/41924873PubMed
40,362,211Understanding the Mechanisms of Chemotherapy-Related Cardiotoxicity Employing hiPSC-Derived Cardiomyocyte Models for Drug Screening and the Identification of Genetic and Epigenetic Variants.Int J Mol Sci2025https://conductscience.org/library/papers/40362211PubMed
39,875,555Anthracycline-induced cardiomyopathy: risk prediction, prevention and treatment.Nat Rev Cardiol2025https://conductscience.org/library/papers/39875555PubMed
38,989,148An update of the molecular mechanisms underlying anthracycline induced cardiotoxicity.Front Pharmacol2024https://conductscience.org/library/papers/38989148PubMed
38,828,138Directly targeting BAX for drug discovery: Therapeutic opportunities and challenges.Acta Pharm Sin B2024https://conductscience.org/library/papers/38828138PubMed
38,173,817Anthracycline-induced cardiotoxicity: mechanisms, monitoring, and prevention.Front Cardiovasc Med2023https://conductscience.org/library/papers/38173817PubMed
38,047,045Doxorubicin Dose Deintensification in Pediatric Osteosarcoma, Is Less Better?South Asian J Cancer2023https://conductscience.org/library/papers/38047045PubMed
37,648,958Empagliflozin attenuates doxorubicin-impaired cardiac contractility by suppressing reactive oxygen species in isolated myocytes.Mol Cell Biochem2024https://conductscience.org/library/papers/37648958PubMed
36,979,503MicroRNA in the Diagnosis and Treatment of Doxorubicin-Induced Cardiotoxicity.Biomolecules2023https://conductscience.org/library/papers/36979503PubMed
36,465,474The role of conventional echocardiographic parameters on detecting subclinical anthracycline therapy related cardiac dysfunction-The SATRACD study.Front Cardiovasc Med2022https://conductscience.org/library/papers/36465474PubMed
35,879,430Exploration of the amino acid metabolic signature in anthracycline-induced cardiotoxicity using an optimized targeted metabolomics approach based on UPLC-MS/MS.Naunyn Schmiedebergs Arch Pharmacol2022https://conductscience.org/library/papers/35879430PubMed
35,845,064Can Dietary Nutrients Prevent Cancer Chemotherapy-Induced Cardiotoxicity? An Evidence Mapping of Human Studies and Animal Models.Front Cardiovasc Med2022https://conductscience.org/library/papers/35845064PubMed
35,796,280Detecting subclinical anthracycline therapy-related cardiac dysfunction in patients attending Uganda Cancer Institute.Future Oncol2022https://conductscience.org/library/papers/35796280PubMed
35,129,819Cardiac Expression of Esophageal Cancer-Related Gene-4 is Regulated by Sp1 and is a Potential Early Target of Doxorubicin-Induced Cardiotoxicity.Cardiovasc Toxicol2022https://conductscience.org/library/papers/35129819PubMed
34,795,719Rational and design of SATRACD study: detecting subclinical anthracycline therapy related cardiac dysfunction in low income country.Afr Health Sci2021https://conductscience.org/library/papers/34795719PubMed
33,669,040Consideration of Sex as a Biological Variable in the Development of Doxorubicin Myotoxicity and the Efficacy of Exercise as a Therapeutic Intervention.Antioxidants (Basel)2021https://conductscience.org/library/papers/33669040PubMed
33,151,075Chemical Architecture of Block Copolymers Differentially Abrogate Cardiotoxicity and Maintain the Anticancer Efficacy of Doxorubicin.Mol Pharm2020https://conductscience.org/library/papers/33151075PubMed
32,776,015A small-molecule allosteric inhibitor of BAX protects against doxorubicin-induced cardiomyopathy.Nat Cancer2020https://conductscience.org/library/papers/32776015PubMed
32,766,291Intramuscular Diphenhydramine Does Not Affect Acute Doxorubicin Infusion-Related Arrhythmia Number or Severity in a Prospective Crossover Study in Canine Lymphoma: A Pilot Study.Front Vet Sci2020https://conductscience.org/library/papers/32766291PubMed
32,628,743Subclinical anthracycline therapy-related cardiac Dysfunction: an ignored stage B heart failure in an African population.Cardiovasc J Afr2020https://conductscience.org/library/papers/32628743PubMed

See all 45 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/5111740

GET https://conductscience.org/api/papers/v1/5111740/cited_by?page=2